2nd Circ. Denies AstraZeneca Investors New Shot At Vax Suit
The Second Circuit on Tuesday affirmed a Manhattan federal judge's dismissal of an investor action targeting COVID-19 vaccine maker AstraZeneca PLC and certain of its executives with claims they misrepresented the...To view the full article, register now.
Already a subscriber? Click here to view full article